Prospective Study of Round Window Versus Cochleostomy Approach to CI Surgery
Status: | Recruiting |
---|---|
Conditions: | Other Indications |
Therapuetic Areas: | Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 1/9/2019 |
Start Date: | May 2015 |
End Date: | May 2020 |
Prospective Randomized Controlled Double-blinded Study Comparing Cochlear Implantation Through a Round Window Versus Cochleostomy Approach
In 1985, the United States Food and Drug Administration (FDA) approved multichannel cochlear
implants (CIs) for adults with profound hearing loss; and in 1990, implantation was approved
for children. Since then, this procedure has become the standard of care for patients with
severe-to-profound sensorineural hearing loss. Successful outcomes are dependent not only on
extrinsic factors, but also on intrinsic factors that cannot always be modified by the CI
team. Significant predictive factors for hearing outcomes in patients with CIs have been
previously reported. These include, but are not limited to, duration of deafness, level of
preimplant speech recognition, pre/postlingual status, and the coupling of device electrodes.
Recipient age does not appear to have a significant impact on hearing outcomes in elderly
candidates.
Earlier studies have found that, because of its dimensions and proximity to the spiral
ganglion cells, the scala tympani (ST) is the preferred location for CI electrode placement.
A number of recent studies have proposed that intraoperative factors may be important
determinants of electrode location and possibly of audiological outcome. Preliminary reports
suggest that intracochlear electrode position- specifically, placement within the ST-is
associated with improved audiological outcomes. Additionally, different surgical techniques
have been proposed to minimize trauma during electrode insertion and to increase the
likelihood of placement within the ST - namely round window and anteroinferior cochleostomy
electrode insertion.
Currently, the best surgical approach for electrode insertion is highly debated, fueled by a
lack of strong evidence to support one method over another. While a number of CI centers have
begun to utilize a round window approach, many large volume centers in the United States and
world wide continue to routinely employ cochleostomy electrode insertions. With an increasing
number of patients being implanted with greater degrees of residual hearing, such data will
become critical towards reducing intracochlear injury and optimizing patient outcomes. To the
investigators' knowledge, no clinical study has prospectively investigated the relationship
between surgical insertion technique, intracochlear electrode location, and postoperative
hearing outcomes. To this end, the investigators are initiating a multicenter prospective
randomized controlled double-blinded study comparing round window and cochleostomy cochlear
implant electrode insertion.
implants (CIs) for adults with profound hearing loss; and in 1990, implantation was approved
for children. Since then, this procedure has become the standard of care for patients with
severe-to-profound sensorineural hearing loss. Successful outcomes are dependent not only on
extrinsic factors, but also on intrinsic factors that cannot always be modified by the CI
team. Significant predictive factors for hearing outcomes in patients with CIs have been
previously reported. These include, but are not limited to, duration of deafness, level of
preimplant speech recognition, pre/postlingual status, and the coupling of device electrodes.
Recipient age does not appear to have a significant impact on hearing outcomes in elderly
candidates.
Earlier studies have found that, because of its dimensions and proximity to the spiral
ganglion cells, the scala tympani (ST) is the preferred location for CI electrode placement.
A number of recent studies have proposed that intraoperative factors may be important
determinants of electrode location and possibly of audiological outcome. Preliminary reports
suggest that intracochlear electrode position- specifically, placement within the ST-is
associated with improved audiological outcomes. Additionally, different surgical techniques
have been proposed to minimize trauma during electrode insertion and to increase the
likelihood of placement within the ST - namely round window and anteroinferior cochleostomy
electrode insertion.
Currently, the best surgical approach for electrode insertion is highly debated, fueled by a
lack of strong evidence to support one method over another. While a number of CI centers have
begun to utilize a round window approach, many large volume centers in the United States and
world wide continue to routinely employ cochleostomy electrode insertions. With an increasing
number of patients being implanted with greater degrees of residual hearing, such data will
become critical towards reducing intracochlear injury and optimizing patient outcomes. To the
investigators' knowledge, no clinical study has prospectively investigated the relationship
between surgical insertion technique, intracochlear electrode location, and postoperative
hearing outcomes. To this end, the investigators are initiating a multicenter prospective
randomized controlled double-blinded study comparing round window and cochleostomy cochlear
implant electrode insertion.
Inclusion criteria are:
- 18 years of age or older,
- less than a 10-year duration of deafness in the ear to be implanted,
- primary surgery,
- normal shaped cochleae,
- no retrocochlear pathology, and
- grossly normal cognitive function.
Exclusion criteria are:
- less than 18 years of age,
- prelingual deafness, or
- greater than 10-years duration of deafness in the ear to be implanted;
- prior otologic surgery in the implanted ear (excluding tympanostomy tube placement),
- inner ear malformation present in the ear to be implanted,
- retrocochlear pathology present in the auditory system to be implanted,
- developmental delay or known cognitive impairment, or
- pregnancy.
We found this trial at
1
site
200 First Street SW
Rochester, Minnesota 55905
Rochester, Minnesota 55905
507-284-2511
Phone: 507-538-1392
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials